Seven Eight Capital, LP Staar Surgical CO Transaction History

Seven Eight Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$30.6 - $43.78 $664,570 - $950,814	21,718 Added 47.04%	67,885 $2.12 Million
Q3 2023 Nov 14, 2023	BUY	$39.39 - $58.12 $1.43 Million - $2.11 Million	36,327 Added 369.18%	46,167 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $72.82 $496,428 - $716,548	9,840 New	9,840 $517,000
Q4 2022 Feb 13, 2023	BUY	$46.82 - $76.2 $583,283 - $949,299	12,458 New	12,458 $604,000
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $227,531 - $330,337	-2,585 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $306,875 - $406,700	-2,500 Reduced 49.16%	2,585 $332,000
Q2 2021 Aug 13, 2021	BUY	$105.76 - $154.96 $537,789 - $787,971	5,085 New	5,085 $775,000
Q4 2018 Feb 14, 2019	SELL	$28.91 - $50.0 $575,309 - $995,000	-19,900 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$30.85 - $50.65 $613,915 - $1.01 Million	19,900 New	19,900 $955,000

249

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.